We have 2 clinical trials underway for Barrett’s Esophagus. This involves comparing conventional screening (with an endoscopy and a biopsy) to an unseated in office procedure. To learn more, click on the links below, or call Rachel, our research coordinator: 303-788-7700 option 3.
This registry collects information about standard antireflux surgical treatment options in everyday clinical practice to better understand the disease and develop better methods to treat it so we may improve patient care.
Now closed. We are the first site in the country and the only site in the Rocky Mountain region to start enrolling patients in the CALIBER study which is a randomized study look at the LINX device compared to taking reflux medications. We enrolled more than any other site in the country. Results to be published soon….
Institute of Esophageal and Reflux Surgery is now enrolling patients for this study.We are participating in a multi center study to look at the use of the LINX Reflux Management System in patients with moderate sized hiatal hernias. We are again the only site in the Rocky Mountain Region to be able to offer this study.
This is a randomized placebo controlled trial to look at the efficacy of the Esophyx device. This study is now closed. Click below to read the results.
This is an ongoing evaluation of patients that have had the Esophyx/TIF procedure to see how they are doing long term. This study is now closed.
We are the only site in the Rocky Mountain Region that was asked to participate in a study to evaluate patients long term who have had the LINX device placed. This is a requirement by the FDA after approving the device for use. This study is now closed.
Prospective study- This is an ongoing study to evaluate all aspects of our care, from testing and diagnosis to outcomes of surgery. By carefully evaluating our data, we are able to improve outcomes, establish quality control, and publish our information.
IERSurgery is now a site for the RELIEF Study- now closed to enrollment.
The purpose of the study is to collect information about the use of the LINX device in patients who have previously undergone a Laparoscopic Sleeve Gastrectomy (LSG). Like other patients with a weak lower esophageal sphincter (LES), post-LSG patients may remain susceptible to gastroesophageal reflux disease (GERD) until the LES barrier function is restored. However, post-LSG patients have limited options for reflux control given their altered gastric anatomy which may not allow them to have standard surgical anti-reflux procedures like fundoplication. The safety and effectiveness of the LINX device has not been established in patients with a previous LSG.
If you have had a sleeve gastrectomy and suffer from reflux, please call 303-788-1636 and talk with Rachel, our research coordinator to learn more.
To see all publications click here.